Advancing the Future of Precision Neurotechnology
MINIGRAPH has brought together leading researchers, clinicians, engineers and innovators across Europe to advance a new generation of minimally invasive neural interface technologies. By combining graphene-based bioelectronics, intelligent implantable systems, robotic implantation approaches and translational research, the project has contributed to expanding the technological foundations required for future adaptive therapies for neurological disorders.
Beyond scientific and technological progress, MINIGRAPH has strengthened collaboration across academia, industry and healthcare, helping to accelerate the translation of emerging neurotechnologies towards real-world clinical applications. The project has generated valuable knowledge, technological assets, scientific publications, intellectual property, stakeholder engagement activities and pathways for future exploitation and clinical adoption.
The outcomes of MINIGRAPH contribute to Europe’s leadership in advanced neurotechnology and support the long-term vision of safer, more effective and more personalised therapies for patients affected by neurological conditions.
For official project information, public deliverables, publications and additional results, visit the European Commission’s CORDIS project page:
Voices of MINIGRAPH: Perspectives on the Future of Neurotechnology
What could the future of brain therapies look like?
In this testimonial video, experts from across the MINIGRAPH ecosystem share their vision for the next generation of neurotechnologies and discuss the transformative potential of graphene neural interfaces. Researchers, clinicians, ethicists and technology developers explain how ultra-thin, highly sensitive graphene-based devices may enable more precise recording and stimulation of brain activity, opening new possibilities for personalised neurological treatments.
The video also explores the role of robotic-assisted implantation, advances in artificial intelligence for neural signal interpretation, and the ethical considerations that accompany emerging brain technologies. Contributors reflect on how these innovations could improve clinical outcomes, reduce invasiveness and support the development of adaptive therapies tailored to individual patients.
Together, these perspectives illustrate the collaborative vision driving MINIGRAPH and highlight the project’s contribution to shaping a future where neuroscience, advanced materials and digital technologies work together to improve the lives of people with neurological disorders.
From Research to Impact: Building the Future of Graphene-Based Brain Therapies
MINIGRAPH has brought together leading researchers, clinicians, engineers and innovators to advance a new generation of graphene-enabled neural interfaces for the treatment of neurological disorders. Through interdisciplinary collaboration, the project has demonstrated how breakthrough materials, advanced electronics, artificial intelligence and robotic-assisted implantation can converge to create safer, more precise and more personalised brain therapies.
This video showcases MINIGRAPH’s scientific journey and highlights the technological building blocks developed throughout the project, from high-resolution neural interfaces and autonomous therapeutic concepts to innovative approaches enabling minimally invasive implantation and next-generation brain-computer interface applications.
By combining graphene technology with advanced sensing, decoding, modulation and microrobotic-assisted implantation strategies, MINIGRAPH contributes to establishing the foundations for future adaptive neurotechnologies capable of delivering more personalised care and improved outcomes for patients affected by neurological disorders.
